Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
100% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | |
|---|---|---|
| Revenue | $22.7K | $33.0K |
| Cost of revenue | $0 | $0 |
| Gross profit | $22.7K | $33.0K |
| Gross margin | 100.0% | 100.0% |
| R&D | $0 | $0 |
| Operating income | −$73.8K | −$942.8K |
| EBITDA | −$73.8K | −$771.1K |
| Net income | −$74.0K | −$943.4K |
| Net margin | -326.0% | -2858.9% |
| EPS (diluted) | -0.00 | 0.00 |
Annual figures · source: Financial Modeling Prep
IBRANDS CORP
No one on the platform currently holds IBRC.
No tracked institution reports a position in IBRC as of their last filing.
| Execution date | Ratio |
|---|---|
| 2013-07-02 | 1-for-1500reverse |
No one on the platform has traded IBRC yet.
| $499056 |
| — |
| MGHCFMinco Capital Corp. | $0.08 | +28.56% | $4M | — |
| NNRINNRF Inc. | $0.00 | +14.29% | $1M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
I have made a lot of dumb decisions and wasted good money on things that felt good. But $IBRC feels like the right one. I’ve been following it for about a year and a half or maybe closer to two years. Every time there would be good news, nothing happened. It just wanted to live between $2-$3. But now, good news really brings the price up, and when the market hits a skid, most days this stays pretty consistent. There are going to be losing days for sure. Those that keep pumping every day like it’s a winning day, let’s live in reality. But I don’t see anything bearish about this anymore. Seems like there is real long term momentum. Who knows where this will go, so let’s all be realistic on the price points. But the potential for a game changer and price point to match are definitely there.
View on StockTwits ↗$TSOI 1/ They NEVER advanced. I still laugh at the claim patents and PRs caused the February 2021 valuation, and then Stocktwits users caused a decline but not the ongoing dilution and nothing being real. Seems TT was starting to wake up with $ENZC chart but still doesn't "get it." There are even hundreds of dead/zombie stocks that ran, I've explained the correlation with original meme stocks. For example, $IBRC. Hugh Kelso (TSOI lawyer) was iBrands CEO. Did he ever question why the dark/defunct, caveat emptor stock ran 2,600% from .0001 for no reason? Funnily enough, it looks like in March 2021 they started pumping that they intend to become current and "other exciting developments," such as a multi-million dollar sales agreement with TSOI, repeating a QuadraMune clinical trial that never happened, followed by a special CBD product produced by TSOI to be provided to some sports team called the Bandits (oh, the irony) that I can't seem to recall Tim ever mentioning.
View on StockTwits ↗$TSOI Haven't been here in awhile...but is the affiliation with $IBRC dead? or is it dead, i can't find a whole lot of info on that. Granted my time too search has been limited, anyone have some insight or answers? Cheers Everyone, Happy Halloween!!
View on StockTwits ↗$IBRC - Ibrands Corp appears to be risky and price may… https://www.macroaxis.com/stock-analysis/IBRC/Ibrands-Corp #insidertrading #stocks #fintechnews
View on StockTwits ↗$IBRC - Is Ibrands Corp better… https://www.macroaxis.com/competition/IBRC/APO/Ibrands-vs-Apollo #portfolio_prospective #better_portfolio #diversify
View on StockTwits ↗$IBRC - Ibrands Corp Three Line Strike event may trigger reversion in March https://www.macroaxis.com/stocks/Pattern-Recognition/Three-Line-Strike/IBRC
View on StockTwits ↗$IBRC $TSOI We have some action! Beautiful! Lets keep it going!
View on StockTwits ↗$TSOI $IBRC IBRC-Start marketing sales back up for Quadramune! https://www.businesswire.com/news/home/20211228005154/en/Therapeutic-Solutions-International-Awarded-Landmark-Patent-for-Cancer-and-COVID-19-Treatment
View on StockTwits ↗$IBRC Lets GO IBRC-Start marketing sales back up for Quadramune! https://www.businesswire.com/news/home/20211228005154/en/Therapeutic-Solutions-International-Awarded-Landmark-Patent-for-Cancer-and-COVID-19-Treatment
View on StockTwits ↗$IBRC - Ibrands Corp appears to be risky and price may… https://www.macroaxis.com/stock-analysis/IBRC/Ibrands-Corp #insidertrading #stocks #fintechnews
View on StockTwits ↗$IBRC well this went nowhere so i guess the fake president and owners stopped pumping out fake news
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.